Literature DB >> 33914293

Genital and Inverse/Intertriginous Psoriasis: An Updated Review of Therapies and Recommendations for Practical Management.

Julie J Hong1, Megan L Mosca2, Edward K Hadeler2, Nicholas D Brownstone2, Tina Bhutani2, Wilson J Liao2.   

Abstract

Genital and inverse psoriasis can develop in more than one-third of patients who have psoriasis. Psoriatic plaques in the genital and intertriginous skin are challenging to treat because the skin is thin and often occluded, making it more sensitive to certain therapies. Traditional guidelines indicate topical therapies, such as corticosteroids, topical calcineurin inhibitors (TCI), and vitamin D analogs as first-line recommendation in treating genital and inverse psoriasis. There have been developments in the treatment of genital and inverse psoriasis using systemic therapies, including IL-17 inhibitors and PDE-4 inhibitors.

Entities:  

Keywords:  Genital; Intertriginous; Inverse; Psoriasis; Special site psoriasis

Year:  2021        PMID: 33914293     DOI: 10.1007/s13555-021-00536-6

Source DB:  PubMed          Journal:  Dermatol Ther (Heidelb)


  49 in total

Review 1.  The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures.

Authors:  Miranda Farage; Howard I Maibach
Journal:  Contact Dermatitis       Date:  2004-10       Impact factor: 6.600

2.  An 18-month-old girl with chronic diaper dermatitis. Psoriasis presenting in the diaper area.

Authors:  Margaret Greco; Sarah L Chamlin
Journal:  Pediatr Ann       Date:  2006-02       Impact factor: 1.132

3.  Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation.

Authors:  Hasan Khosravi; Michael P Siegel; Abby S Van Voorhees; Joseph F Merola
Journal:  J Drugs Dermatol       Date:  2017-08-01       Impact factor: 2.114

4.  Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.

Authors:  M G Lebwohl; M H Tan; S L Meador; G Singer
Journal:  J Am Acad Dermatol       Date:  2001-01       Impact factor: 11.527

5.  Genital psoriasis awareness program: physical and psychological care for patients with genital psoriasis.

Authors:  Kim A P Meeuwis; Joanne A de Hullu; Joanna IntHout; Iris M P Hendriks; Emilie E Sparreboom; Leon F A G Massuger; Peter C M van de Kerkhof; Michelle M van Rossum
Journal:  Acta Derm Venereol       Date:  2015-02       Impact factor: 4.437

6.  Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

Authors:  Alan Menter; Neil J Korman; Craig A Elmets; Steven R Feldman; Joel M Gelfand; Kenneth B Gordon; Alice B Gottlieb; John Y M Koo; Mark Lebwohl; Henry W Lim; Abby S Van Voorhees; Karl R Beutner; Reva Bhushan
Journal:  J Am Acad Dermatol       Date:  2009-06-03       Impact factor: 11.527

Review 7.  Vulvar psoriasis in adults and children: a clinical audit of 194 cases and review of the literature.

Authors:  Shivam Kapila; Jennifer Bradford; Gayle Fischer
Journal:  J Low Genit Tract Dis       Date:  2012-10       Impact factor: 1.925

Review 8.  Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.

Authors:  Gottfried Wozel
Journal:  Clin Dermatol       Date:  2008 Sep-Oct       Impact factor: 3.541

9.  The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis.

Authors:  Joseph F Merola; Alison Potts Bleakman; Alice B Gottlieb; Alan Menter; April N Naegeli; Robert Bissonnette; Lyn Guenther; John Sullivan; Kim Meeuwis; Kyoungah See; Kristina Callis Duffin
Journal:  J Drugs Dermatol       Date:  2017-08-01       Impact factor: 2.114

Review 10.  Psoriasis in special localizations.

Authors:  Klaudia Dopytalska; Piotr Sobolewski; Agata Błaszczak; Elżbieta Szymańska; Irena Walecka
Journal:  Reumatologia       Date:  2018-12-23
View more
  1 in total

1.  Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis.

Authors:  Marco Galluzzo; Marina Talamonti; Arnaldo Cioni; Virginia Maffei; Ruslana Gaeta Shumak; Lorenzo Tofani; Luca Bianchi; Elena Campione
Journal:  J Clin Med       Date:  2022-05-07       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.